Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

1.

Probiotics for the prevention or treatment of chemotherapy- or radiotherapy-related diarrhoea in people with cancer.

Wei D, Heus P, van de Wetering FT, van Tienhoven G, Verleye L, Scholten RJ.

Cochrane Database Syst Rev. 2018 Aug 31;8:CD008831. doi: 10.1002/14651858.CD008831.pub3.

PMID:
30168576
2.

Probiotics for the prevention of pediatric antibiotic-associated diarrhea.

Guo Q, Goldenberg JZ, Humphrey C, El Dib R, Johnston BC.

Cochrane Database Syst Rev. 2019 Apr 30;4:CD004827. doi: 10.1002/14651858.CD004827.pub5.

PMID:
31039287
3.

Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.

Goldenberg JZ, Yap C, Lytvyn L, Lo CK, Beardsley J, Mertz D, Johnston BC.

Cochrane Database Syst Rev. 2017 Dec 19;12:CD006095. doi: 10.1002/14651858.CD006095.pub4. Review.

4.

Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers.

Lawrie TA, Green JT, Beresford M, Wedlake L, Burden S, Davidson SE, Lal S, Henson CC, Andreyev HJN.

Cochrane Database Syst Rev. 2018 Jan 23;1:CD012529. doi: 10.1002/14651858.CD012529.pub2. Review.

5.

Moxibustion for alleviating side effects of chemotherapy or radiotherapy in people with cancer.

Zhang HW, Lin ZX, Cheung F, Cho WC, Tang JL.

Cochrane Database Syst Rev. 2018 Nov 13;11:CD010559. doi: 10.1002/14651858.CD010559.pub2.

PMID:
30480754
6.

Probiotics for the prevention of pediatric antibiotic-associated diarrhea.

Johnston BC, Goldenberg JZ, Vandvik PO, Sun X, Guyatt GH.

Cochrane Database Syst Rev. 2011 Nov 9;(11):CD004827. doi: 10.1002/14651858.CD004827.pub3. Review. Update in: Cochrane Database Syst Rev. 2015;12:CD004827.

PMID:
22071814
7.

Probiotics for the prevention of pediatric antibiotic-associated diarrhea.

Goldenberg JZ, Lytvyn L, Steurich J, Parkin P, Mahant S, Johnston BC.

Cochrane Database Syst Rev. 2015 Dec 22;(12):CD004827. doi: 10.1002/14651858.CD004827.pub4. Review. Update in: Cochrane Database Syst Rev. 2019 Apr 30;4:CD004827.

PMID:
26695080
8.

Vaccines for preventing rotavirus diarrhoea: vaccines in use.

Soares-Weiser K, Bergman H, Henschke N, Pitan F, Cunliffe N.

Cochrane Database Syst Rev. 2019 Mar 25;3:CD008521. doi: 10.1002/14651858.CD008521.pub4.

9.

Probiotics for treating eczema.

Makrgeorgou A, Leonardi-Bee J, Bath-Hextall FJ, Murrell DF, Tang ML, Roberts A, Boyle RJ.

Cochrane Database Syst Rev. 2018 Nov 21;11:CD006135. doi: 10.1002/14651858.CD006135.pub3.

PMID:
30480774
10.

Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units.

Toews I, George AT, Peter JV, Kirubakaran R, Fontes LES, Ezekiel JPB, Meerpohl JJ.

Cochrane Database Syst Rev. 2018 Jun 4;6:CD008687. doi: 10.1002/14651858.CD008687.pub2. Review.

11.

Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.

Moelands SV, Lucassen PL, Akkermans RP, De Grauw WJ, Van de Laar FA.

Cochrane Database Syst Rev. 2018 Dec 28;12:CD005061. doi: 10.1002/14651858.CD005061.pub3.

PMID:
30592787
12.

Epidermal growth factor receptor blockers for the treatment of ovarian cancer.

Morrison J, Thoma C, Goodall RJ, Lyons TJ, Gaitskell K, Wiggans AJ, Bryant A.

Cochrane Database Syst Rev. 2018 Oct 16;10:CD007927. doi: 10.1002/14651858.CD007927.pub4.

PMID:
30321910
13.

Interventions for the prevention of recurrent erysipelas and cellulitis.

Dalal A, Eskin-Schwartz M, Mimouni D, Ray S, Days W, Hodak E, Leibovici L, Paul M.

Cochrane Database Syst Rev. 2017 Jun 20;6:CD009758. doi: 10.1002/14651858.CD009758.pub2. Review.

14.

Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.

Candy B, Jones L, Vickerstaff V, Larkin PJ, Stone P.

Cochrane Database Syst Rev. 2018 Jun 5;6:CD006332. doi: 10.1002/14651858.CD006332.pub3. Review.

15.

Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.

Mikocka-Walus A, Prady SL, Pollok J, Esterman AJ, Gordon AL, Knowles S, Andrews JM.

Cochrane Database Syst Rev. 2019 Apr 12;4:CD012680. doi: 10.1002/14651858.CD012680.pub2.

PMID:
30977111
16.

Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).

Ruospo M, Palmer SC, Natale P, Craig JC, Vecchio M, Elder GJ, Strippoli GF.

Cochrane Database Syst Rev. 2018 Aug 22;8:CD006023. doi: 10.1002/14651858.CD006023.pub3.

PMID:
30132304
17.

Glucocorticosteroids for people with alcoholic hepatitis.

Pavlov CS, Varganova DL, Casazza G, Tsochatzis E, Nikolova D, Gluud C.

Cochrane Database Syst Rev. 2019 Apr 9;4:CD001511. doi: 10.1002/14651858.CD001511.pub4.

18.

Cannabis for the treatment of Crohn's disease.

Kafil TS, Nguyen TM, MacDonald JK, Chande N.

Cochrane Database Syst Rev. 2018 Nov 8;11:CD012853. doi: 10.1002/14651858.CD012853.pub2.

PMID:
30407616
19.

Interventions for treating genital Chlamydia trachomatis infection in pregnancy.

Cluver C, Novikova N, Eriksson DO, Bengtsson K, Lingman GK.

Cochrane Database Syst Rev. 2017 Sep 22;9:CD010485. doi: 10.1002/14651858.CD010485.pub2. Review.

20.

Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.

Abdel-Rahman O, Elsayed Z, Elhalawani H.

Cochrane Database Syst Rev. 2018 Apr 6;4:CD011746. doi: 10.1002/14651858.CD011746.pub2. Review.

Supplemental Content

Support Center